Phentermine is a phenethylamine primarily used as an appetite suppressant. It is typically prescribed for individuals who are at increased medical risk because of their weight, as opposed to cosmetic weight loss.
Phentermine is sold either as an immediate-release formulation (Adipex®) or as a slow-release resin (Ionamin®, Duromine® in Australia and New Zealand).
History
Phentermine is one of two drugs in the
Fen-phen anti-
obesity medication, the other being
fenfluramine or
dexfenfluramine. Fenfluramine was withdrawn from the
U.S. market in
1997 after reports of
valvular heart disease and
pulmonary hypertension.
Phentermine is still available by itself in most countries, including the U.S. However, because it is similar to the amphetamines, individuals may develop an addiction to it. Hence, it is classified as a controlled substance in many countries. Internationally, phentermine is a schedule IV drug under the Convention on Psychotropic Substances (PDF file). In the United States, it is classified as a Schedule IV controlled substance under the Controlled Substances Act.
Mechanism of action
Phentermine, as many other prescription drugs, works with
neurotransmitters in the brain. It is a centrally-acting
stimulant chemically related to the
amphetamines. It stimulates
neuron bundles to release a particular group of neurotransmitters known as
catecholamines; these include
dopamine,
epinephrine (also known as adrenalin), and
norepinephrine (noradrenaline).
The anorectic activity seen with these compounds would thus seem likely due to this effect on
Central Nervous System, which is consistent with current knowledge about Central Nervous System systems and feeding behavior. This is the same
mechanism of action as other stimulant appetite suppresants such as
diethylpropion, and
phendimetrazine.
The neurotransmitters signal a fight-or-flight response in the body which, in turn, puts a halt to the hunger signal. As a result, it causes a loss in appetite because the brain does not receive the hunger message.
Clinical use
Generally, it is recommended by the
Food and Drug Administration (FDA) that phentermine should be used short-term (usually interpreted as 'up to 12 weeks'), while following nonpharmacological approaches to weight loss such as healthy
dieting and
exercise. However, recommendations limiting its use for short-term treatment may be controversial. One reason given behind limiting its use to 12 weeks is
drug tolerance, whereby phentermine loses its appetite-suppressing effects after the body adjusts to the drug. On the contrary, it has been shown that phentermine did not lose effectiveness in a 36-week trial (PMID 11054601).
Due to the risk of
insomnia, it is generally recommended that the drug be taken either before breakfast or 1-2 hours after breakfast.
Side effects
Generally, phentermine appears to be relatively well tolerated.
It can produce side effects consistent with its catecholaminereleasing
properties, e.g.,
tachycardia, increased alertness, but the incidence and magnitude of these appear to be less than with the amphetamines. Because phentermine acts through
sympathomimetic pathways, the drug may increase
blood pressure and
heart rate. It may also cause
palpitations, restlessness, and
insomnia. Additionally, individuals taking this drug on a long-term basis may develop euphoria and a
psychological addiction to it.
Contraindications
Phentermine should generally be avoided in patients with:
Additionally, this drug should not be used at the same time or within 14 days following the use of monoamine oxidase inhibitors.
Internet Notoriety
Recently, phentermine has drawn the ire of many internet users. The medication is one of the most commonly used terms in spam e-mails and bulletin board postings by bots.
Related Article
External links
References and End Notes
obesity | Antiobesity agents | Anorectics | Pharmacologic agents | Phenethylamines | Stimulants | Schedule IV controlled substances
Fentermina